Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024VisiongainApril 16, 2009 133 Pages - SKU: VSG2274650 |
|
Global Biosimilars Market Forecast to 2015
3/1/2012 | published by: RNCOS
The biosimilars industry has been growing stupendously across the globe for past few years. Increasing healthcare costs and rising aging population are driving the industry, which stands at a vivid position and is expected to
|
more...
|
$1,500.00
|
|
Biosimilars: Current Situation & Future Prospects, Worldwide
3/1/2012 | published by: JustPharmaReports.com
The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry. On this basis, prospects for biosimilars look good, with the vast majority of leading originator brands in the global
|
more...
|
$3,000.00
|
|
Analysis of European Biosimilars Market
12/20/2011 | published by: Frost & Sullivan
The aim of this research study is to thoroughly assess and analyse the biosimilars market, as well as market and technology trends in Europe, in order to provide strategic recommendations for the success of market
|
more...
|
$6,500.00
|
|
Specialty Physicians Discuss their Opinions of the United States Biosimilars Market
12/8/2011 | published by: Frost & Sullivan
The U.S. biosimilars market is a fast approaching reality. However, much uncertainty lies ahead, including the market potential as a function of physician adoption of biosimilars. This panel discussion was conducted to preview the thoughts
|
more...
|
$10,000.00
|
|
Global Biosimilars: A return to optimism?
1/23/2012 | published by: Espicom Healthcare Intelligence
Despite some commentators predicting a muted or near nonexistent market for advanced biosimilars, many companies - and some surprising names - are positioning themselves for market
|
more...
|
$2,265.00
|
|
Hot Topics in Multiple Sclerosis: US Prescriber Perception of Biosimilars - Brands to lose over a fifth of patients to copy-cat drugs
8/31/2011 | published by: Datamonitor
This report analyzes the potential impact of biosimilar multiple sclerosis therapies according to perceptions of US prescribers. The analysis is designed to provide an understanding of the biosimilar opportunities and implications to current players. Introduction With healthcare
|
more...
|
$3,800.00
|
|
Biosimilars: China Update
9/22/2011 | published by: Datamonitor
Biosimilars: China Update provides analysis on the Chinese biogenerics market. It includes an overview of drivers and resistors to biogeneric uptake, market access strategies, key biogeneric players and future development trends. Introduction Currently, there is no definition,
|
more...
|
$1,900.00
|
|
Global Biotechnology Market
6/1/2011 | published by: Taiyou Research
Biotechnology has become the foundation on which the pharmaceutical industry and many others are progressing on. The biotech revolution has surpassed the IT revolution as well and has become the new engine of the global
|
more...
|
$500.00
|
|
Hospital Injectable Drugs: Future Prospects for Generics & Biosimilars
7/25/2011 | published by: Espicom Healthcare Intelligence
The generic injectables sector exceeds US$11.2 billion and numerous high-value injectable products will face patent expiry in major markets over the next decade. This critical new report evaluates the markets, players and products in detail.
|
more...
|
$2,265.00
|
|
Biosimilar Opportunities: Pipelines and Companies
9/1/2011 | published by: Decision Resources
The multibillion dollar biosimilars opportunity is an extremely attractive commercial prospect. A considerable volume of biosimilars research is under way in emerging markets. More global business development will be triggered by key patent expiries in
|
more...
|
$4,600.00
|
